| Presenter: Jane van Renen | Guest(s): Richard Friedland |
- Click here to listen to the interview
Summit TV speaks to Netcare chief executive officer Richard Friedland about results that include a 12% increase in revenue and 15% increase in operating profit and the outlook for their UK and South African operations
Jane van Renen: Richard, in terms of Netcare’s interim results you’ve got a 12% increase in revenue and a 15% increase in operating profit with businesses in the United Kingdom and South Africa – can you take us through the break down in terms of the results and how those two locations have impacted on the results?
Richard Friedland: As you’ve pointed out two very different geographies. Netcare is very much a tale of two countries – at a turnover or revenue level it’s about fifty-fifty, at an operating profit point of view the bulk of the operating profits is generated in the United Kingdom, but from an earnings point of view at the bottom line the majority of earnings comes from South Africa.
Jane van Renen: Can you explain how that works?
Richard Friedland: That’s because of the higher debt burden in the United Kingdom so 89% of our earnings is generated now in South Africa, and 11% is generated in the United Kingdom. As we de-gear the United Kingdom we will see those earnings increase. It’s important for viewers to understand that actually in terms of the size of the operations Netcare in South Africa is three times the size of our operations in the UK – it’s just the relative strength between the rand and the pound that gives you the split in turnover.
Jane van Renen: In terms of your acquisition strategy can you take us through that particular path in the UK specifically?
Richard Friedland: The UK is undergoing a lot of challenging economic pressures at the moment and there are opportunities that arise for us – in this past year we’ve been able to make four acquisitions, and we’ve done this at a very low capital cost because effectively we are taking over the operating companies and not the property companies where effectively we are taking over a lease. What that has done for us is to increase our presence in the centre of London – where we’ve been particularly weak -and generally across the United Kingdom – and that’s now allowed us to take a 36% share of the UK private healthcare market we are now the number one player. In South Africa growth has been purely organic.
Jane van Renen: How are you managing to get rid of your debt?
Richard Friedland: One of the most pleasing aspects of our results for this six months is that we’ve reduced our gearing on the South African balance sheet by R1.8billion and that’s about a 30% reduction in debt in six months.
Jane van Renen: Is part of that due to the sale of your stake in Ampath Laboratories?
Richard Friedland: Correct. Part of that is due to the sale of Ampath – those proceeds only came late in March so we will probably only see the interest reduction in the next six months. A lot is due to a focus on working capital management – we have very low debtors days, and we’ve been very focused on conversion of cash in the business. If you look at the UK that debt is fixed – it’s secured against the properties, it’s at 6.5% -and that will be de-geared over time as we increase our operating profits.
Jane van Renen: In terms of operating in the private segment obviously the recession is going to hit private healthcare even harder – the forecasts say that – how are you planning to buffer yourselves against that?
Richard Friedland: We’ve seen very strong demand for private Healthcare both here and in the United Kingdom despite the recessionary environment. Right across the board if you look at our hospitals, pharmacies, and emergency services or primary care we’ve seen 6.3% growth in our hospital patient days – and that’s despite what’s essentially a downturn in the SA economy. Like wise in the UK we’ve seen a lot of National Health System (NHS) patients coming into our hospitals choosing the private sector. Of course we are down in terms of cash patients out of pocket – they are preserving cash preferring to go the NHS. Where we have seen an impact is more at our primary care level where we are treating lower income patients – remember Primecure is a lower income market product where we are trying to bring on more lives within the medical aid environment, and there we have taken greater provisions for bad or doubtful debt and we are just being more prudent.
Jane van Renen: What’s your relationship like with the National Healthcare System there?
Richard Friedland: We have an excellent relationship with the NHS. That’s something we built up before we got involved with General Healthcare Group (GHG). One of our tenets in Netcare is to be a credible partner to government – because ultimately we believe we can help improve accessibility to Healthcare. We have a number of projects with the NHS in the UK and obviously we are looking to emulate those public private partnerships here in South Africa.
Jane van Renen: How much pressure will South African regulations in terms of tariff structures put on your operating margins?
Richard Friedland: We don’t believe that there are those kinds of pressures at the moment – but healthcare is always a regulated sector so we are not naive believing there will never be regulations. We are confident that we can justify the tariffs that are charged at the moment and we can justify the efficiencies that are brought to bear. I think many people forget the real asset of private healthcare in this country and the wonderful access – if you can afford it if you’re on a medical aid that you can get. I think our real challenge is to expand that to more.
Jane van Renen: Expansion very briefly – any acquisition targets for the rest of Africa?
Richard Friedland: I think where we are heading with Africa is through our public private partnerships. If you look at what we’ve done in Lesotho that’s the largest public private partnership in healthcare in Africa in partnership with that government – not only are we building a 420-bed facility, we are going to be running all the medical and nursing facilities and the primary care facilities. It’s underpinned by the World Bank and the International Finance Corporation (IFC). We think it’s a great project that has sustainability in Africa – if we can develop that I think there’s a lot of expansion there.
Transcripts: 082 962 2772